| 1 |
32785161 | Design of Curcumin and Flavonoid Derivatives with Acetylcholinesterase and Beta-Secretase Inhibitory Activities Using in Silico Approaches. | 2020 Aug 10 |
2 |
| 2 |
32867308 | Synthesis, In Silico and In Vitro Evaluation for Acetylcholinesterase and BACE-1 Inhibitory Activity of Some N-Substituted-4-Phenothiazine-Chalcones. | 2020 Aug 27 |
1 |
| 3 |
32899576 | Synthesis, In Silico and In Vitro Evaluation of Some Flavone Derivatives for Acetylcholinesterase and BACE-1 Inhibitory Activity. | 2020 Sep 5 |
1 |
| 4 |
33010267 | Flavonoids as BACE1 inhibitors: QSAR modelling, screening and in vitro evaluation. | 2020 Dec 15 |
1 |
| 5 |
33073981 | Scope of β-Secretase (BACE1)-Targeted Therapy in Alzheimer's Disease: Emphasizing the Flavonoid Based Natural Scaffold for BACE1 Inhibition. | 2020 Nov 4 |
3 |
| 6 |
25779965 | Galangin-induced down-regulation of BACE1 by epigenetic mechanisms in SH-SY5Y cells. | 2015 May 21 |
1 |
| 7 |
21982844 | Flavonoids, cognition, and dementia: actions, mechanisms, and potential therapeutic utility for Alzheimer disease. | 2012 Jan 1 |
1 |
| 8 |
22243648 | New tacrine-4-oxo-4H-chromene hybrids as multifunctional agents for the treatment of Alzheimer's disease, with cholinergic, antioxidant, and β-amyloid-reducing properties. | 2012 Feb 9 |
3 |
| 9 |
21077260 | Antidiabetic complications and anti-Alzheimer activities of sophoflavescenol, a prenylated flavonol from Sophora flavescens, and its structure-activity relationship. | 2011 May |
1 |
| 10 |
21738321 | Flavonoids lower Alzheimer's Aβ production via an NFκB dependent mechanism. | 2011 |
12 |
| 11 |
18295609 | Flavonols and flavones as BACE-1 inhibitors: structure-activity relationship in cell-free, cell-based and in silico studies reveal novel pharmacophore features. | 2008 May |
4 |